| Dr Robert Lafitte Eller, MD | |
|
1 Doctors Dr, Greenville, SC 29605-4266 | |
| (864) 572-7001 | |
| (864) 412-0645 |
| Full Name | Dr Robert Lafitte Eller |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 1 Doctors Dr, Greenville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164482683 | NPI | - | NPPES |
| 390053 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 39005 (South Carolina) | Secondary |
| 207Y00000X | Otolaryngology | 39005 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| Prisma Health Patewood Hospital | Greenville, SC | Hospital |
| Prisma Health Baptist Easley Hospital | Easley, SC | Hospital |
| Prisma Health Greer Memorial Hospital | Greer, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greenville Ent And Allergy Associates Pa | 5395158653 | 20 |
News Archive
SIRS-Lab GmbH, a molecular diagnostics company based in Jena, Germany, and Pfizer Pharma GmbH, headquartered in Berlin, have announced a collaboration in the field of sepsis.
Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears in the July 10, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
"This issue has been building for some time. It is really no surprise as insects have become resistant to nearly all insecticides given time and selection pressure. Few new chemicals are in development for malaria vector control, because there is little profit to be made by the poorest of the world's poor — who feel the brunt of the malaria burden.
In this Atlantic Magazine opinion piece, Megan McArdle, senior editor at the Atlantic, echoes a warning by the FDA issued in 2001 which stated, "Unless antibiotic resistance problems are detected as they emerge, and actions are taken to contain them, the world could be faced with previously treatable diseases that have again become untreatable, as in the days before antibiotics were developed."
› Verified 9 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
SIRS-Lab GmbH, a molecular diagnostics company based in Jena, Germany, and Pfizer Pharma GmbH, headquartered in Berlin, have announced a collaboration in the field of sepsis.
Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears in the July 10, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
"This issue has been building for some time. It is really no surprise as insects have become resistant to nearly all insecticides given time and selection pressure. Few new chemicals are in development for malaria vector control, because there is little profit to be made by the poorest of the world's poor — who feel the brunt of the malaria burden.
In this Atlantic Magazine opinion piece, Megan McArdle, senior editor at the Atlantic, echoes a warning by the FDA issued in 2001 which stated, "Unless antibiotic resistance problems are detected as they emerge, and actions are taken to contain them, the world could be faced with previously treatable diseases that have again become untreatable, as in the days before antibiotics were developed."
› Verified 9 days ago
| Entity Name | Greenville Ent And Allergy Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649875816 PECOS PAC ID: 5395158653 Enrollment ID: O20210105001174 |
News Archive
SIRS-Lab GmbH, a molecular diagnostics company based in Jena, Germany, and Pfizer Pharma GmbH, headquartered in Berlin, have announced a collaboration in the field of sepsis.
Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears in the July 10, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
"This issue has been building for some time. It is really no surprise as insects have become resistant to nearly all insecticides given time and selection pressure. Few new chemicals are in development for malaria vector control, because there is little profit to be made by the poorest of the world's poor — who feel the brunt of the malaria burden.
In this Atlantic Magazine opinion piece, Megan McArdle, senior editor at the Atlantic, echoes a warning by the FDA issued in 2001 which stated, "Unless antibiotic resistance problems are detected as they emerge, and actions are taken to contain them, the world could be faced with previously treatable diseases that have again become untreatable, as in the days before antibiotics were developed."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Lafitte Eller, MD 1 Doctors Dr, Greenville, SC 29605-4266 Ph: (864) 572-7001 | Dr Robert Lafitte Eller, MD 1 Doctors Dr, Greenville, SC 29605-4266 Ph: (864) 572-7001 |
News Archive
SIRS-Lab GmbH, a molecular diagnostics company based in Jena, Germany, and Pfizer Pharma GmbH, headquartered in Berlin, have announced a collaboration in the field of sepsis.
Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears in the July 10, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
"This issue has been building for some time. It is really no surprise as insects have become resistant to nearly all insecticides given time and selection pressure. Few new chemicals are in development for malaria vector control, because there is little profit to be made by the poorest of the world's poor — who feel the brunt of the malaria burden.
In this Atlantic Magazine opinion piece, Megan McArdle, senior editor at the Atlantic, echoes a warning by the FDA issued in 2001 which stated, "Unless antibiotic resistance problems are detected as they emerge, and actions are taken to contain them, the world could be faced with previously treatable diseases that have again become untreatable, as in the days before antibiotics were developed."
› Verified 9 days ago
Dr. Augustus J Goforth Iii, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 131 Commonwealth Dr, Suite 230, Greenville, SC 29615 Phone: 864-281-9440 Fax: 864-281-9443 | |
Gustavo Guimaraes Rangel, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 Patewood Dr Ste B400, Greenville, SC 29615 Phone: 864-454-4368 Fax: 864-241-9232 | |
Robert A Wilson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4200 E North St Ste 16, Greenville, SC 29615 Phone: 864-292-2800 Fax: 864-292-2921 | |
Edward Benjamin Penn Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 Patewood Dr Ste B400, Greenville, SC 29615 Phone: 864-522-8603 | |
Dr. Ronald T Yuko, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 131 Commonwealth Dr, Suite 290, Greenville, SC 29615 Phone: 864-281-9440 Fax: 864-281-9443 | |
Dr. Leighanne Hoskins Dorton, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Doctors Dr, Greenville, SC 29605 Phone: 864-572-7001 |